Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

BUY
$62.17 - $97.62 $1.47 Million - $2.3 Million
23,572 New
23,572 $2.3 Million
Q2 2022

Aug 01, 2022

SELL
$84.23 - $147.57 $185,895 - $325,686
-2,207 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$122.89 - $171.74 $32,320 - $45,167
-263 Reduced 10.65%
2,207 $306,000
Q4 2021

Feb 08, 2022

BUY
$156.0 - $265.78 $146,952 - $250,364
942 Added 61.65%
2,470 $451,000
Q3 2021

Nov 12, 2021

SELL
$228.69 - $274.2 $280,373 - $336,169
-1,226 Reduced 44.52%
1,528 $395,000
Q2 2021

Aug 13, 2021

BUY
$169.89 - $231.37 $101,933 - $138,822
600 Added 27.86%
2,754 $633,000
Q1 2021

May 14, 2021

BUY
$143.93 - $207.3 $63,617 - $91,626
442 Added 25.82%
2,154 $363,000
Q4 2020

Feb 09, 2021

BUY
$96.1 - $151.18 $164,523 - $258,820
1,712 New
1,712 $249,000

Others Institutions Holding HSKA

About HESKA CORP


  • Ticker HSKA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 10,818,900
  • Description
  • Heska Corporation sells veterinary and animal health diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and ...
More about HSKA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.